Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Summary of changes: added a government operating-status notice and a new 196-week clinical trial publication citation, and updated the software version from v3.1.0 to v3.2.0; the prior version tag v3.1.0 was removed.
    Difference
    2%
    Check dated 2025-10-04T00:45:15.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page updates to Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content.
    Difference
    0.1%
    Check dated 2025-09-26T18:09:48.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Standardizes location naming from ‘Tatarstan Republic’ to ‘Tatarstan, Respublika’ and from ‘Tatarstan Republic, Russia’ to ‘Tatarstan, Respublika, Russia’ for the Kazan address.
    Difference
    0.1%
    Check dated 2025-09-19T12:35:01.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and the Back to Top element was removed; core content, pricing, stock, and time-slot information remain unchanged.
    Difference
    0.1%
    Check dated 2025-09-12T08:43:27.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-05T03:59:08.000Z thumbnail image
  9. Check
    60 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as new information related to drug safety and efficacy for Risankizumab. Notably, the previous version's location details have been largely replaced or removed.
    Difference
    15%
    Check dated 2025-08-29T01:48:36.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.